Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Enbridge Inc (ENB) vs Twist Bioscience Corp (TWST) Price & Performance

Enbridge IncTrade
Twist Bioscience CorpTrade

Price performance (Past 24H)

Key statistics

Enbridge Inc vs Twist Bioscience Corp — how do they compare? Enbridge Inc trades at $51.67 (market cap $112.62B), while Twist Bioscience Corp trades at $124 (market cap $7.72B). The key difference: Enbridge Inc is far larger — about 14.6× Twist Bioscience Corp's market cap, and Enbridge Inc pays a 5.34% dividend while Twist Bioscience Corp pays none. Which is the better fit depends on your goals.

ENBTWST
Market Cap
$112.62B$7.72B
Sector
EnergyHealth
52-Week High
$58.04$124.88
52-Week Low
$45.23$24.16
Enterprise Value
$196.53B$7.65B
Dividend Yield
5.34%

Returns comparison

Trailing returns across standard periods

About Enbridge Inc

Enbridge owns extensive midstream assets that transport hydrocarbons across the U.S. and Canada. Its pipeline network consists of the Canadian Mainline system, regional oil sands pipelines, and natural gas pipelines. The company also owns and operates a regulated natural gas utility and Canada's largest natural gas distribution company. Finally, the firm has a small renewables portfolio primarily focused on onshore and offshore wind projects.

Read more on ENB

About Twist Bioscience Corp

Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies. Powering cost-effective, rapid high-throughput synthesis, it enables researchers to rapidly realize opportunities ahead. Geographically, it derives a majority of revenue from the United States.

Read more on TWST